TEMENOS
28.5.2020 08:32:10 CEST | Business Wire | Press release
Temenos (SIX: TEMN), the banking software company, today announced that Banco Itaú (Suisse) SA and Banco Itaú International, affiliates belonging to one of the world’s largest private bank groups, Itaú Unibanco Holding SA (Itaú), have extended their relationship with Temenos to rapidly deploy Temenos Infinity Wealth and Temenos Transact on Temenos SaaS. Temenos’ cloud-native, cloud-agnostic, API-first technology will power the bank’s international private banking operations on a single, universal wealth management platform with rich functionality, spanning back-office processing through to front-office portfolio management. Temenos SaaS will provide a resilient, secure and fully compliant service to power Itaú’s private banking operations in Switzerland and the U.S. The shift to a single SaaS digital banking platform will drastically reduce the bank’s time-to-market, IT costs and operational complexity and achieve an improved cost/income ratio.
Temenos’ superior technology brings the benefits of SaaS, including accelerated and remote deployment, scalability and efficiencies, combined with elastic cost structure on cloud infrastructure.
Itaú Unibanco is the largest bank in Latin American, offering a broad range of retail, corporate, investment banking and asset management services for clients around the world. Itaú Unibanco has operations in 19 countries throughout the Americas, Europe and Asia. Temenos has been a partner of Itaú’s since 2017. Itaú Private Bank International has selected Temenos Infinity Wealth and Temenos Transact delivered by Temenos SaaS to gain synergies and efficiencies across its global operations by implementing a single digital wealth platform.
The agility, scalability and security of Temenos SaaS combined with the Temenos Model Bank approach provides pre-configured, country-specific functionality for the U.S. and Switzerland. Amid the ongoing COVID-19 pandemic, Temenos SaaS will enable Itaú Private Bank International to benefit from unrivalled levels of business resilience and security.
SaaS-powered Temenos Infinity Wealth, the leading omnichannel digital banking product, and Temenos Transact, the next generation in core banking, will drive operational efficiency throughout the business, allowing Itaú Private Bank International to free up resources formerly dedicated to IT infrastructure and focus on delivering seamless, digital customer experiences. The new digital platform will also support Itaú Private Bank International to increase its assets under management and customer base and scale its business in an agile and sustainable way. Temenos SaaS is continuously deployed 24X7, X365 days per year, delivering highly efficient, elastic scalability and automatically provisioning resources to perfectly match demand upwards or downwards.
Fernando Beyruti, Head of Itaú Private Bank International, said: “Investing in technology that can drive sustainable profitability, efficiency and client centricity is a key pillar of Itaú Private Bank International’s business strategy. With Temenos’ advanced, cloud-native technology, we will keep our attention and focus on the business. The rapid launch of our new, truly universal digital wealth platform supports our international operations and enables us to scale for global expansion in years to come.”
Max Chuard, Chief Executive Officer, Temenos, said: “We are excited to extend our partnership with Itaú, one of the largest banks in the world, as they embrace the power of the cloud to achieve operational excellence for their international private banking business. We are pioneers in cloud software and we have global banking expertise in rapidly deploying SaaS solutions in highly regulated environments. Temenos SaaS will provide Itaú Private Bank International with cost and scalability benefits, high security and availability. Temenos Infinity Wealth and Temenos Transact will transform Itaú Private Bank International’s entire business, from front to back office. Amid the global uncertainty surrounding the COVID-19 pandemic, Itaú Private Bank International will reap the benefits of a highly resilient and secure cloud offering, reduced time to market, and will be able to deliver outstanding digital customer experiences.”
– Ends –
About Itaú Unibanco Holding SA
Itaú Unibanco, with over 90 years of history, is the largest private bank in Latin America. Present in 19 countries in the Americas, Europe and Asia, it has more than 90 thousand employees and serves individual and corporate customers in all segments.
About Temenos
Temenos AG (SIX: TEMN) is the world’s leader in banking software. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 500 million banking customers. Temenos offers cloud-native, cloud-agnostic and AI-driven front office, core banking, payments and fund administration software enabling banks to deliver frictionless, omnichannel customer experiences and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve cost-income ratios of 26.8% half the industry average and returns on equity of 29%, three times the industry average. These clients also invest 51% of their IT budget on growth and innovation versus maintenance, which is double the industry average, proving the banks’ IT investment is adding tangible value to their business.
For more information, please visit www.temenos.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200527005611/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom